Worth a Look
Qualify for a free subscription to HealthLeaders magazine.
“Bandages” and “shrimp” are two words you don’t expect to hear in the same sentence. But for one Portland, OR-based company, they go together just fine.
HemCon Medical Technologies worked with the U.S. Army to develop a bandage made from chitosan, a naturally occurring, biocompatible substance derived from shrimp shells. The shells are processed, treated, formed into bandages and sterilized. The idea is that the chitosan attracts blood cells and seals a wound to allow the body to form a clot that stops hemorrhaging. And what if the patient has a shellfish allergy? HemCon says no known allergic reactions have occurred since the product launched in 2003.
Originally developed for use on the battlefield, the dressings are now used in acute-care settings through a distributorship agreement reached last fall with Dublin, OH-based Cardinal Health. Go to either www.hemcon.com or www.cardinalhealth.com to read more.
- EHR Systems 'Immature, Costly,' AMA Says
- Anthem Blue Cross, 7 CA Health Systems Create New Challenger, Business Model
- Interstate Medical Licensure Effort Advances
- Better HCAHPS Scores Protect Revenue
- Data Points to Boom in Private HIX
- How to Build a Health Plan from Scratch
- Few Winners Among MSSP Participants
- CEO Exchange: Preparing for Population Health
- Narrow Networks Cut Costs, Not Quality, Economists Say
- Insurers see cost hikes in Partners HealthCare (MA) mergers